Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pimicotinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abbisko announces that EMA has granted orphan drug designation forPimicotinib
    Abbisko announces that EMA has granted orphan drug designation forPimicotinib

    08 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbisko-therapeutic-announces-that-ema-has-granted-orphan-drug-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302028394.html

    PR NEWSWIRE
    08 Jan 2024
    Share Share
    Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib
    Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib

    13 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbisko-therapeutics-announces-that-us-fda-has-granted-fast-track-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302014220.html

    PR NEWSWIRE
    13 Dec 2023
    Share Share
    Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio
    Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio

    04 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231129696616/en

    BUSINESSWIRE
    04 Dec 2023
    Share Share